A Phase I Study of Nilontinib and Cetuximab in Patients With Solid Tumors
Clinical trial NCT01871311 · TERMINATED
Trial details
- NCT number
- NCT01871311
- Sponsor
- Georgetown University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2016-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.